Our first review/perspective is out! Here we look into the role of stereochemistry in screening library design, prioritization of actionable targets, and molecular complexity of FDA approved drugs. It was a great pleasure to work on this manuscript with Kevin Scott, Nathalie Ropek, Bruno Melillo, Stuart Schreiber, and Ben Cravatt!